The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Disc Medicine, Inc. | COM | 254604101 | 14,065,311 | 243,513 | SH | SOLE | 243,513 | 0 | 0 | |||
Hims & Hers Health, Inc. | COM CL A | 433000106 | 34,117,091 | 3,833,381 | SH | SOLE | 3,833,381 | 0 | 0 | |||
Kinnate Biopharma Inc. | COM | 49705R105 | 8,356,518 | 3,525,957 | SH | SOLE | 3,525,957 | 0 | 0 | |||
Theseus Pharmaceuticals, Inc. | COM | 88369M101 | 16,640,624 | 4,108,796 | SH | SOLE | 4,108,796 | 0 | 0 | |||
23andMe Holding Co. | CLASS A COM | 90138Q108 | 212,115 | 232,200 | SH | SOLE | 232,200 | 0 | 0 |